Our lead products are based on over 20 years of academic research into the fundamental biology of scar formation, fibrosis and regenerative medicine. The groundbreaking work of Renovo's co-founders produced a wealth of potential drug targets on the strength of which Renovo was launched. Further research within Renovo discovered additional new targets and further developed a selection of those towards clinical evaluation.
A comprehensive list of publications is available from the download in the Related Items to the right >>
Printer-friendly version